JP4559531B1 - Method for producing nobiletin - Google Patents

Method for producing nobiletin Download PDF

Info

Publication number
JP4559531B1
JP4559531B1 JP2009275181A JP2009275181A JP4559531B1 JP 4559531 B1 JP4559531 B1 JP 4559531B1 JP 2009275181 A JP2009275181 A JP 2009275181A JP 2009275181 A JP2009275181 A JP 2009275181A JP 4559531 B1 JP4559531 B1 JP 4559531B1
Authority
JP
Japan
Prior art keywords
nobiletin
added
formula
solution
och3
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2009275181A
Other languages
Japanese (ja)
Other versions
JP2011116696A (en
Inventor
敏幸 菅
敏幸 脇本
倫宏 浅川
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ushio Chemix Corp
Original Assignee
Ushio Chemix Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ushio Chemix Corp filed Critical Ushio Chemix Corp
Priority to JP2009275181A priority Critical patent/JP4559531B1/en
Application granted granted Critical
Publication of JP4559531B1 publication Critical patent/JP4559531B1/en
Publication of JP2011116696A publication Critical patent/JP2011116696A/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

【課題】ノビレチンおよびその誘導体の製造方法の提供。
【解決手段】β-ジケトン合成とそれに続くフラボン環化反応により、ノビレチンおよびその誘導体を合成する方法:
また、標識されたヨウ化メチルと反応させることにより、標識する方法。
【選択図】なし
A method for producing nobiletin and its derivatives is provided.
A method for synthesizing nobiletin and its derivatives by β-diketone synthesis and subsequent flavone cyclization reaction:
A method of labeling by reacting with labeled methyl iodide.
[Selection figure] None

Description

本発明は、ノビレチンの新規合成方法および標識方法に関する。   The present invention relates to a novel synthesis method and labeling method of nobiletin.

ある種の柑橘類に含まれるノビレチンは、抗高血圧、抗癌作用などの多様な生理活性を示すことが報告されている(例えば、WO2006/049234)。また、アルツハイマー性記憶障害改善作用や抗認知症活性についても注目を集めている。ノビレチンは食品成分であり、服用における安全性が高いと考えられる。そのため、生理作用の機序が解明されれば、安全な医薬品としての応用が期待できる。   It has been reported that nobiletin contained in certain citrus fruits exhibits various physiological activities such as antihypertensive and anticancer effects (for example, WO2006 / 049234). In addition, attention has been focused on Alzheimer's memory impairment improving action and antidementia activity. Nobiletin is a food ingredient and is considered to be highly safe in taking. Therefore, if the mechanism of physiological action is elucidated, application as a safe pharmaceutical product can be expected.

しかしながら、現在試薬として入手可能なノビレチンは天然物から抽出したものであり、精製にコストがかかるため高価である。また、ノビレチンの各種の誘導体も得られていない。このため、構造活性相関の研究や、動物に及ぼす影響の研究はほとんど行われていない。   However, nobiletin currently available as a reagent is extracted from natural products and is expensive because of the cost of purification. In addition, various derivatives of nobiletin have not been obtained. For this reason, there has been little research on structure-activity relationships or effects on animals.

WO2006/049234WO2006 / 049234

本発明は、ノビレチンおよびその誘導体の新規な合成方法、ならびにノビレチンおよびその誘導体の選択的標識方法を提供することを目的とする。   An object of the present invention is to provide a novel method for synthesizing nobiletin and its derivatives, and a method for selective labeling of nobiletin and its derivatives.

本発明は、式(I):
[式中、RはHまたはメチルである]
で表される化合物(ノビレチンまたはその5−OH誘導体)を合成する方法を提供する。この方法は、
(a)式(II):
で表される化合物と式(III):
(式中、R ンゾトリアゾリルを表す)
で表される化合物とを反応させて、式(IV):
で表される化合物を製造し;
(b)式(IV)の化合物を環化させて、式(V):
で表される化合物を製造し;
(c)任意に、式(V)の化合物をAlCl3およびエタンチオールと反応させて、式(VI):
で表される化合物を製造する;
の各工程を含む。


The present invention is directed to formula (I):
[Wherein R 1 is H or methyl]
A compound represented by the formula (nobiletin or a 5-OH derivative thereof) is synthesized. This method
(A) Formula (II):
And a compound represented by formula (III):
(Wherein, R represents base Nzotoriazoriru)
Is reacted with a compound represented by formula (IV):
A compound represented by:
(B) cyclizing the compound of formula (IV) to form formula (V):
A compound represented by:
(C) Optionally reacting the compound of formula (V) with AlCl 3 and ethanethiol to give formula (VI):
A compound represented by the formula:
Including each step.


別の観点においては、本発明は、式(VII):
[式中、*Meは11Cまたは14Cで標識されたメチル基を表す]
で表される化合物を製造する方法を提供する。この方法は、式(V):
の化合物をAlCl3およびエタンチオールと反応させて、式(VI):
で表される化合物を製造し;
式(VI)の化合物を塩基の存在下で11Cまたは14Cで標識されたヨウ化メチルと反応させることにより、式(VII)の化合物を得る、
の各工程を含む。
In another aspect, the present invention provides a compound of formula (VII):
[Wherein * Me represents a methyl group labeled with 11 C or 14 C]
The method of manufacturing the compound represented by this is provided. This method uses the formula (V):
Is reacted with AlCl 3 and ethanethiol to give the formula (VI):
A compound represented by:
Reacting a compound of formula (VI) with methyl iodide labeled with 11 C or 14 C in the presence of a base to give a compound of formula (VII),
Including each step.

本発明の方法にしたがえば、ノビレチンおよびその種々の誘導体を容易かつ簡便に合成することができ、選択的に標識することができる。   According to the method of the present invention, nobiletin and its various derivatives can be synthesized easily and conveniently and can be selectively labeled.

本発明は、効率的なβ-ジケトン合成とそれに続くフラボン環化反応により、ノビレチン(1):
およびその誘導体を合成する方法を提供する。
The present invention provides nobiletin (1) by efficient β-diketone synthesis followed by flavone cyclization reaction:
And methods for synthesizing derivatives thereof.

なお、本明細書の全体を通して、フラボン類の環および置換基の位置は次式:
にしたがって表記する。
Throughout this specification, the positions of the flavones rings and substituents are represented by the following formula:
Notation according to

本発明の方法の第1工程においては、フラボンA環部に相当するアセトフェノン誘導体(8)に対し、フラボンB環部に相当するジメトキシ安息香酸誘導体(9)(RはClまたはベンゾトリアゾリルである)を、THF 中 LHMDS(リチウムヘキサメチルジシラジド)処理により作用させ、フラボン前駆体である β- ジケトン(10)を得る。
In the first step of the method of the present invention, the acetophenone derivative (8) corresponding to the flavone A ring portion is changed to the dimethoxybenzoic acid derivative (9) corresponding to the flavone B ring portion (R is Cl or benzotriazolyl). ) Is treated by treatment with LHMDS (lithium hexamethyldisilazide) in THF to obtain β-diketone (10) which is a flavone precursor.

フラボンのA環部に対応する出発物質であるアセトフェノン誘導体(8):
は以下のようにして製造することができる。まず、下記の4ステップにより、1,2,3,5-テトラメトキシベンゼン(2)の4位に水酸基を導入して、2,3,4,6- テトラメトキシフェノール(6)を生成する。
Acetophenone derivative (8) which is the starting material corresponding to the A ring part of flavone:
Can be produced as follows. First, a hydroxyl group is introduced into the 4-position of 1,2,3,5-tetramethoxybenzene (2) by the following four steps to produce 2,3,4,6-tetramethoxyphenol (6).

出発物質である1,2,3,5-テトラメトキシベンゼンは市販されている。まず、1,2,3,5-テトラメトキシベンゼンに対して、フリーデル・クラフツ反応により(3)を生成する。フリーデル・クラフツ反応は、非プロトン性溶媒中で、塩化アルミニウム等のルイス酸の存在下で塩化アセチルと反応させることにより行うことができる。塩基性条件下でヨウ化メチルと反応させることにより(3)をメチル化して、1-(2,3,4,6-テトラメトキシフェニル)エタノン(4)を生成する。次に、SeO2触媒の存在下で過酸化水素を作用させて、バイヤー・ビリガー反応により(4)のケトンをエステル化して(5)を生成し、過溶媒分解により2,3,4,6-テトラメトキシフェノール (6) を得ることができる。 The starting material 1,2,3,5-tetramethoxybenzene is commercially available. First, (3) is produced by Friedel-Crafts reaction with 1,2,3,5-tetramethoxybenzene. The Friedel-Crafts reaction can be carried out by reacting with acetyl chloride in the presence of a Lewis acid such as aluminum chloride in an aprotic solvent. Methylation of (3) by reaction with methyl iodide under basic conditions produces 1- (2,3,4,6-tetramethoxyphenyl) ethanone (4). Next, hydrogen peroxide is allowed to act in the presence of a SeO 2 catalyst, and the ketone of (4) is esterified by the Bayer-Billiger reaction to produce (5), and 2,3,4,6 by persolvolysis. -Tetramethoxyphenol (6) can be obtained.

次に、2,3,4,6-テトラメトキシフェノール (6) の4位の水酸基にメチル基を導入してペンタメトキシフェノール(7)とする。メチル化は、塩基性条件下でヨウ化メチルと反応させることにより行う。
Next, a methyl group is introduced into the hydroxyl group at the 4-position of 2,3,4,6-tetramethoxyphenol (6) to form pentamethoxyphenol (7). Methylation is performed by reacting with methyl iodide under basic conditions.

次に、(7)の化合物をアシル化して、フラボンのA環部に対応するアセトフェノン誘導体(8)を得る。アシル化は、フリーデル・クラフツ反応により第1工程と同様にして行うことができる。
Next, the compound (7) is acylated to obtain an acetophenone derivative (8) corresponding to the A-ring part of the flavone. The acylation can be carried out in the same manner as in the first step by Friedel-Crafts reaction.

また、本発明の方法においてフラボンB環部に相当する出発物質である、ジメトキシ安息香酸誘導体(9'):
は、市販の3,4−ジメトキシ安息香酸を塩化チオニルと反応させることにより得られ、アシルベンゾトリアゾール(9"):
は、上記で得られた酸クロリドを塩基の存在下でベンゾトリアゾールと反応させることにより得ることができる。
In addition, a dimethoxybenzoic acid derivative (9 ′), which is a starting material corresponding to the flavone B ring in the method of the present invention:
Is obtained by reacting commercially available 3,4-dimethoxybenzoic acid with thionyl chloride, acyl benzotriazole (9 "):
Can be obtained by reacting the acid chloride obtained above with benzotriazole in the presence of a base.

本発明の方法の第2工程においては、第1工程で得られたβ- ジケトンを環化させることにより、目的とするノビレチン(1)を得る。環化は、メタノール中TFAによる酸処理により行う。
In the second step of the method of the present invention, the target nobiletin (1) is obtained by cyclizing the β-diketone obtained in the first step. Cyclization is performed by acid treatment with TFA in methanol.

本発明の方法の任意の工程である第3工程においては、ノビレチン(1)をAlCl3およびエタンチオールと反応させることにより、A環の5位が脱メチル化された誘導体を製造する。
In the third step, which is an optional step of the method of the present invention, a derivative in which the 5-position of the A ring is demethylated is produced by reacting nobiletin (1) with AlCl 3 and ethanethiol.

以上の工程により、下記のノビレチンおよびその誘導体を合成することができる。
Through the above steps, the following nobiletin and its derivatives can be synthesized.

本発明の別の態様においては、ノビレチンの選択的標識化の方法が提供される。
In another aspect of the invention, a method for selective labeling of nobiletin is provided.

この方法では、上述の第3工程と同様にして、ノビレチンをAlCl3およびエタンチオールで処理することにより選択的に5位を脱メチル化し、次に、DMF 中、塩基の存在下で11Cまたは14C で標識化したヨウ化メチルを用いて加熱することで、容易に5 位のメチル基が標識されたノビレチン(1*)を得ることができる。このようにして標識したノビレチンは、PET測定やトレース実験に有用である。 In this method, similar to the third step described above, nobiletin is selectively demethylated by treating it with AlCl 3 and ethanethiol, then 11 C or D 11 in DMF in the presence of a base. By heating with methyl iodide labeled with 14 C, nobiletin (1 *) labeled with the methyl group at the 5-position can be easily obtained. Nobiletin labeled in this way is useful for PET measurements and trace experiments.

本発明の方法は、精製にカラムクロマトグラフィーを必要としないため、スケールアップが容易である。さらに、本発明の方法と既知の有機合成法を適宜組み合わせて、A環のメトキシ基やB環のトリアゾールユニットを変えることにより、ノビレチンの各種の誘導体の合成ならびにその位置選択的標識化が可能である。今後、ノビレチンの更なる誘導体化、例えばビオチンタグ化、蛍光プローブの導入等により、その生理作用機序の解明に大きく寄与できるものと考えられる。   Since the method of the present invention does not require column chromatography for purification, it can be easily scaled up. Furthermore, various combinations of nobiletin and regioselective labeling are possible by appropriately combining the method of the present invention and known organic synthesis methods and changing the A ring methoxy group and the B ring triazole unit. is there. In the future, it is considered that further derivatization of nobiletin, for example, biotin tagging, introduction of a fluorescent probe, etc. can greatly contribute to elucidation of the physiological action mechanism.

以下に実施例により本発明をより詳細に説明するが、本発明はこれらの実施例により限定されるものではない。   EXAMPLES The present invention will be described below in more detail with reference to examples, but the present invention is not limited to these examples.

実施例1:1-(2-ヒドロキシ-3,4,6-トリメトキシフェニル)エタノン(3)の合成
氷零下、塩化アルミニウム 1.5 g, 10.6 mL を乾燥ジエチルエーテル溶液 7.5 mL に溶解し 10 分間拡販後、同温度下で 1,2,3,5-テトラメトキシベンゼン(2) 1.5 g, 7.57 mmol のジエチルエーテル溶液を加えた室温下にて 10 分間撹拌した。続いて塩化アセチル 714 μL, 9.8 mmol を室温下加え、溶液をそのまま 4 時間撹拌した。TLC にて反応の完結を確認した後、反応液を 0 ℃に氷零し 6N 塩酸にて反応を停止した。反応液にトルエンを加え抽出した。有機層より 1N 水酸化ナトリウム水溶液にて抽出を行い、水層が pH 2 になるまで 6N 塩酸をゆっくり加えた。析出する固体をろ取し、1-(2-ヒドロキシ-3,4,6-トリメトキシフェニル)エタノン(3) (1.3 g, 収率 76%) を淡黄色結晶として得た。
1H NMR (500 MHz, CDCl3): d 13.8 (s, 1H, OH), 5.97 (s 1H, Ar), 3.94 (s, 3H, OCH3), 3.90 (s, 3H, OCH3), 3.82 (s, 3H, OCH3), 2.62 (s, 3H, CH3).
Example 1: Synthesis of 1- (2-hydroxy-3,4,6-trimethoxyphenyl) ethanone (3)
Dissolve aluminum chloride (1.5 g, 10.6 mL) in dry diethyl ether solution (7.5 mL) under ice-free conditions, expand the sales for 10 minutes, and then, at the same temperature, 1,2,3,5-tetramethoxybenzene (2) 1.5 g, 7.57 mmol of diethyl The mixture was stirred for 10 minutes at room temperature with the ether solution added. Subsequently, 714 μL of acetyl chloride, 9.8 mmol was added at room temperature, and the solution was stirred as it was for 4 hours. After confirming the completion of the reaction by TLC, the reaction solution was cooled to 0 ° C. and quenched with 6N hydrochloric acid. Toluene was added to the reaction solution and extracted. The organic layer was extracted with 1N aqueous sodium hydroxide solution, and 6N hydrochloric acid was slowly added until the aqueous layer reached pH 2. The precipitated solid was collected by filtration to give 1- (2-hydroxy-3,4,6-trimethoxyphenyl) ethanone (3) (1.3 g, yield 76%) as pale yellow crystals.
1H NMR (500 MHz, CDCl3): d 13.8 (s, 1H, OH), 5.97 (s 1H, Ar), 3.94 (s, 3H, OCH3), 3.90 (s, 3H, OCH3), 3.82 (s, 3H , OCH3), 2.62 (s, 3H, CH3).

実施例2:1-(2,3,4,6-テトラメトキシフェニル) エタノン(4)の合成
1-(2-ヒドロキシ-3,4,6-トリメトキシフェニル)エタノン(3) 16 g, 71 mmolをジメチルホルムアミド 80 mL に溶解し、室温下、炭酸カリウム 20 g, 145 mmol とヨウ化メチル6.6 mL, 106 mmol を順次加え、反応液を 60 ℃に加熱し1時間半撹拌した。 TLC にて反応の完結を確認した後、反応液を室温に冷やし、続いてジエチルエーテル 200 mLを加え、不溶性の塩をセライトろ過にて除いた。ろ液を水、飽和食塩水により洗浄後、有機層をとり、無水硫酸マグネシウムを加え乾燥した。ろ過後、ろ液を減圧濃縮し、1-(2,3,4,6-テトラメトキシフェニル) エタノン(4) (17 g, 収率 94%) を淡黄色油状物として得た。
1H NMR (500 MHz, CDCl3): d 6.26 (s, 1H, Ar), 3.89 (s, 6H, OCH3), 3.81 (s, 3H, OCH3), 3.80 (s, 3H, OCH3), 2.48 (s, 3H, CH3).
Example 2: Synthesis of 1- (2,3,4,6-tetramethoxyphenyl) ethanone (4)
1- (2-Hydroxy-3,4,6-trimethoxyphenyl) ethanone (3) 16 g, 71 mmol is dissolved in dimethylformamide 80 mL, and at room temperature, potassium carbonate 20 g, 145 mmol and methyl iodide 6.6 mL, 106 mmol were sequentially added, and the reaction solution was heated to 60 ° C. and stirred for 1.5 hours. After confirming completion of the reaction by TLC, the reaction solution was cooled to room temperature, 200 mL of diethyl ether was added, and insoluble salts were removed by Celite filtration. The filtrate was washed with water and saturated brine, and the organic layer was taken and dried over anhydrous magnesium sulfate. After filtration, the filtrate was concentrated under reduced pressure to give 1- (2,3,4,6-tetramethoxyphenyl) ethanone (4) (17 g, yield 94%) as a pale yellow oil.
1H NMR (500 MHz, CDCl3): d 6.26 (s, 1H, Ar), 3.89 (s, 6H, OCH3), 3.81 (s, 3H, OCH3), 3.80 (s, 3H, OCH3), 2.48 (s, 3H, CH3).

実施例3:2,3,4,6- テトラメトキシフェノール(6)の合成
1-(2,3,4,6-テトラメトキシフェニル) エタノン(4)の tert- ブタノール溶液に、室温下、二酸化セレンを加え、反応液を 50 ℃まで加熱する。同温度下、30% 過酸化水素水を 10 分間かけて滴下し、そのまま 10 時間撹拌した。NMRにて反応の完結を確認した後、反応液を室温に冷やし、続いてベンゼン 200 mL を加えた。有機層を飽和塩化アンモニウム水溶液にて 4 回洗浄後、有機層をとり、無水硫酸マグネシウムを加え乾燥した。ろ過後、ろ液を減圧濃縮し、2,3,4,6-テトラメトキシフェニルアセテート(5)を橙色固形物として得た。
2,3,4,6-テトラメトキシフェニルアセテート(5)のメタノール溶液にアルゴン雰囲気、室温下炭酸カリウムを加え撹拌した。TLC にて反応の完結を確認した後、反応液を 0 ℃に氷零し 6N 塩酸にて反応液が pH 1 になるまで加え反応を停止した。 続いてジエチルエーテル 200 mL を加え、抽出を 5 回行った後に無水硫酸ナトリウムにて乾燥した。ろ過後、ろ液を減圧濃縮し 2,3,4,6- テトラメトキシフェノール(6)を白色針状結晶として得た。
1H NMR (500 MHz, CDCl3): d 6.33 (s, 1H, Ar), 5.23 (s, 1H, OH), 3.96 (s, 3H, OCH3), 3.87 (s, 3H, OCH3), 3.84 (s, 3H, OCH3), 3.83 (s, 3H, OCH3).
Example 3: Synthesis of 2,3,4,6-tetramethoxyphenol (6)
Selenium dioxide is added to a tert-butanol solution of 1- (2,3,4,6-tetramethoxyphenyl) ethanone (4) at room temperature, and the reaction mixture is heated to 50 ° C. Under the same temperature, 30% aqueous hydrogen peroxide was added dropwise over 10 minutes, and the mixture was stirred for 10 hours. After confirming the completion of the reaction by NMR, the reaction solution was cooled to room temperature, and then 200 mL of benzene was added. The organic layer was washed four times with a saturated aqueous ammonium chloride solution, then the organic layer was taken, dried over anhydrous magnesium sulfate. After filtration, the filtrate was concentrated under reduced pressure to obtain 2,3,4,6-tetramethoxyphenyl acetate (5) as an orange solid.
To a methanol solution of 2,3,4,6-tetramethoxyphenyl acetate (5), potassium carbonate was added and stirred at room temperature under an argon atmosphere. After confirming the completion of the reaction by TLC, the reaction solution was cooled to 0 ° C. with ice, and the reaction solution was added with 6N hydrochloric acid until the reaction solution reached pH 1 to stop the reaction. Subsequently, 200 mL of diethyl ether was added and extraction was performed 5 times, followed by drying over anhydrous sodium sulfate. After filtration, the filtrate was concentrated under reduced pressure to obtain 2,3,4,6-tetramethoxyphenol (6) as white needle crystals.
1H NMR (500 MHz, CDCl3): d 6.33 (s, 1H, Ar), 5.23 (s, 1H, OH), 3.96 (s, 3H, OCH3), 3.87 (s, 3H, OCH3), 3.84 (s, 3H, OCH3), 3.83 (s, 3H, OCH3).

実施例4:ペンタメトキシベンゼン(7)の合成
2,3,4,6-テトラメトキシフェニノール(6)とヨウ化メチルのアセトン溶液にアルゴン雰囲気下炭酸カリウムを加え、そのまま撹拌した。TLC にて反応の完結を確認した後、反応液を室温に冷やし、続いてジエチルエーテル 200 mL を加え、不溶性の塩をセライトろ過にて除いた。ろ液を減圧濃縮し、シリカゲルカラムクロマトグラフィー (展開溶媒ヘキサン : 酢酸エチル = 6:1) にて精製後、ペンタメトキシベンゼン(7)を白色固体として得た。
1H NMR (270 MHz, CDCl3): d 6.30 (s, 1H, Ar), 3.95 (s, 3H, OCH3), 3.85 (s, 6H, OCH3), 3.83 (s, 6H, OCH3); 13C NMR (67.8 MHz, CDCl3): d 149.1, 147.8, 136.8, 93.8, 61.4, 61.3, 56.4; MS (FAB) m/z calcd for C11H17O5+ (M+H) + 228, 実測値 228.
Example 4: Synthesis of pentamethoxybenzene (7)
To an acetone solution of 2,3,4,6-tetramethoxypheninol (6) and methyl iodide was added potassium carbonate under an argon atmosphere, and the mixture was stirred as it was. After confirming the completion of the reaction by TLC, the reaction solution was cooled to room temperature, 200 mL of diethyl ether was added, and insoluble salts were removed by Celite filtration. The filtrate was concentrated under reduced pressure and purified by silica gel column chromatography (developing solvent hexane: ethyl acetate = 6: 1) to obtain pentamethoxybenzene (7) as a white solid.
1H NMR (270 MHz, CDCl3): d 6.30 (s, 1H, Ar), 3.95 (s, 3H, OCH3), 3.85 (s, 6H, OCH3), 3.83 (s, 6H, OCH3); 13C NMR (67.8 (MHz, CDCl3): d 149.1, 147.8, 136.8, 93.8, 61.4, 61.3, 56.4; MS (FAB) m / z calcd for C11H17O5 + (M + H) + 228, measured 228.

実施例5:1-(2-ヒドロキシ-3,4,5,6-テトラメトキシフェニル)エタノン(8)の合成
ペンタメトキシベンゼン(7) 1.5 g, 6.6 mmol の乾燥塩化メチレン溶液 16 mL に、氷零下、塩化アセチル 728 μL, 9.8 mmol を加え、続いて塩化アルミニウム 900 mg, 10.6 mmol を加え、溶液を室温で 4 時間撹拌した。氷零後、反応液にジエチルエーテルを加え、次いで pH 11 になるまで 2N 水酸化ナトリウム水溶液を加えた。有機層をとり、無水硫酸マグネシウムを加え乾燥した。ろ過後、ろ液を減圧濃縮し、原料のペンタメトキシベンゼン (1.0 g, 回収率 66%) を回収した。また、水層をとり、ジエチルエーテルで洗浄後、氷零下、pH 1 になるまで 6N 塩酸を加えた。水溶液をジエチルエーテルで 3 回抽出し、有機層をとり、無水硫酸マグネシウムを加え乾燥した。ろ過後、ろ液を減圧濃縮し、残渣をフラッシュシリカゲルカラムクロマトグラフィー (展開溶媒ヘキサン:酢酸エチル = 4:1 → 2:1) にて精製し、1-(2-ヒドロキシ-3,4,5,6-テトラメトキシフェニル)エタノン(500 mg, 収率 30%) を黄色油状物質として得た。
回収した原料を再び乾燥塩化メチレン 10 mL に溶解し、 氷零下、塩化アセチル 485μL, 6.2 mmol を加え、続いて塩化アルミニウム 560 mg, 6.6 mmol を加え、溶液を室温で 4 時間撹拌した。氷零後、反応液にジエチルエーテルを加え、次いで pH 11 になるまで 2N 水酸化ナトリウム水溶液を加えた。 有機層をとり、無水硫酸マグネシウムを加え乾燥した。ろ過後、ろ液を減圧濃縮し、原料のペンタメトキシベンゼン (513 mg, 回収率51%) を回収した。また、水層をとり、ジエチルエーテルで洗浄後、氷零下、pH 1になるまで 6N 塩酸を加えた。水溶液をジエチルエーテルで 3 回抽出し、有機層をとり、無水硫酸マグネシウムを加え乾燥した。ろ過後、ろ液を減圧濃縮し、残渣をフラッシュシリカゲルカラムクロマトグラフィー(展開溶媒ヘキサン:酢酸エチル = 4:1 → 2:1) にて精製し、1-(2-ヒドロキシ-3,4,5,6-テトラメトキシフェニル)エタノン (508 mg, 収率 45%) を黄色油状物質として得た。それらを合わせ、1-(2-ヒドロキシ-3,4,5,6-テトラメトキシフェニル)エタノン(8) (1.0 g, 収率 60%) と、 原料のペンタメトキシベンゼン (513 mg, 回収率 34%) を得た。
1H NMR (500 MHz, CDCl3): d 13.2 (s, 1H, OH), 4.08 (s, 3H, OCH3), 3.95 (s, 3H, OCH3) , 3.90 (s, 3H, OCH3), 3.95 (s, 3H, OCH3) (s, 3H, OCH3).
Example 5: Synthesis of 1- (2-hydroxy-3,4,5,6-tetramethoxyphenyl) ethanone (8)
To 16 mL of a dry methylene chloride solution of 1.5 g, 6.6 mmol of pentamethoxybenzene (7), 728 μL of acetyl chloride, 9.8 mmol was added under zero ice, followed by 900 mg of aluminum chloride, 10.6 mmol, and the solution was added at room temperature. Stir for hours. After zero ice, diethyl ether was added to the reaction solution, and then 2N aqueous sodium hydroxide solution was added until pH 11 was reached. The organic layer was taken and dried over anhydrous magnesium sulfate. After filtration, the filtrate was concentrated under reduced pressure to recover the raw material pentamethoxybenzene (1.0 g, recovery 66%). Further, the aqueous layer was taken, washed with diethyl ether, and 6N hydrochloric acid was added until the pH reached 1 under zero ice. The aqueous solution was extracted 3 times with diethyl ether, the organic layer was taken, dried over anhydrous magnesium sulfate. After filtration, the filtrate was concentrated under reduced pressure, and the residue was purified by flash silica gel column chromatography (developing solvent hexane: ethyl acetate = 4: 1 → 2: 1) to give 1- (2-hydroxy-3,4,5 , 6-Tetramethoxyphenyl) ethanone (500 mg, 30% yield) was obtained as a yellow oil.
The recovered raw material was dissolved again in 10 mL of dry methylene chloride, and acetyl chloride (485 μL, 6.2 mmol) was added under ice zero, followed by the addition of aluminum chloride (560 mg, 6.6 mmol), and the solution was stirred at room temperature for 4 hours. After zero ice, diethyl ether was added to the reaction solution, and then 2N aqueous sodium hydroxide solution was added until pH 11 was reached. The organic layer was taken and dried over anhydrous magnesium sulfate. After filtration, the filtrate was concentrated under reduced pressure to recover the raw material pentamethoxybenzene (513 mg, 51% recovery). The aqueous layer was taken, washed with diethyl ether, and 6N hydrochloric acid was added until the pH reached 1 under zero ice. The aqueous solution was extracted 3 times with diethyl ether, the organic layer was taken, dried over anhydrous magnesium sulfate. After filtration, the filtrate was concentrated under reduced pressure, and the residue was purified by flash silica gel column chromatography (developing solvent hexane: ethyl acetate = 4: 1 → 2: 1) to give 1- (2-hydroxy-3,4,5 , 6-Tetramethoxyphenyl) ethanone (508 mg, 45% yield) was obtained as a yellow oil. Combining them, 1- (2-hydroxy-3,4,5,6-tetramethoxyphenyl) ethanone (8) (1.0 g, 60% yield) and the raw material pentamethoxybenzene (513 mg, yield 34) %).
1H NMR (500 MHz, CDCl3): d 13.2 (s, 1H, OH), 4.08 (s, 3H, OCH3), 3.95 (s, 3H, OCH3), 3.90 (s, 3H, OCH3), 3.95 (s, 3H, OCH3) (s, 3H, OCH3).

実施例6:(1H-ベンゾ [d][1,2,3]トリアゾ-1-イル)(3,4-ジメトキシフェニル)メタノン(9")の合成
2,3-ジメトキシ安息香酸 15 g, 82 mmol の塩化メチレン溶液 200mL に、アルゴン雰囲気下 0 ℃で、塩化チオニル 9.0 mL, 123 mLとジメチルホルムアミド 2.5 mL, 33 mmol を加えそのまま 1 時間半撹拌した。その後、減圧下濃縮し、残渣を乾燥塩化メチレン 170 mL に再び溶解させ、アルゴン雰囲気下 0 ℃でトリエチルアミン 11.4 mL, 82 mmol、次いで、ベンゾトリアゾール 9.8 g, 82 mmol を順次加え、そのまま 30 分撹拌した。その後、1N 水酸化ナトリウム水溶液を加え、有機層をとり、無水硫酸マグネシウムを加え乾燥した。ろ過後、ろ液を減圧濃縮し、残渣より再結晶 (溶媒ヘキサン-塩化メチレン) にて (1H-ベンゾ [d][1,2,3]トリアゾ-1-イル)(3,4-ジメトキシフェニル)メタノン(9") (19 g, 収率 82%) を白色固体として得た。
1H NMR (500 MHz, CDCl3): d 8.37 (d, J = 8.5 Hz, 1H, Ar), 8.05(d, J = 8.5, 1H, Ar), 7.82 (s, 1H, Ar), 7.70 (t, J = 7.5 Hz, 1H, Ar), 7.55 (t, J = 7.5 Hz, 1H, Ar), 7.04 (d, J = 7.5 Hz, 1H, Ar), 4.01 (s, 3H, OCH3), 4.00 (s, 3H, OCH3); 13C NMR (125 MHz, CDCl3): d 165.5, 153.9, 148.7, 145.5, 132.5, 130.2, 127.2, 126.1, 123.3, 120.0, 114.8, 113.9, 110.2, 56.1, 56.0; MS (FAB) m/z calcd for C15H14N3O3+ (M+H) + 283, 実測値 283.
Example 6: Synthesis of (1H-benzo [d] [1,2,3] triazo-1-yl) (3,4-dimethoxyphenyl) methanone (9 ")
Thionyl chloride 9.0 mL, 123 mL and dimethylformamide 2.5 mL, 33 mmol were added to 200 mL of a methylene chloride solution of 2,3-dimethoxybenzoic acid 15 g, 82 mmol in an argon atmosphere at 0 ° C., followed by stirring for 1 hour and a half. After concentration under reduced pressure, the residue was redissolved in 170 mL of dry methylene chloride. Triethylamine 11.4 mL, 82 mmol, and then benzotriazole 9.8 g, 82 mmol were sequentially added at 0 ° C. under an argon atmosphere, and the mixture was stirred as it was for 30 minutes. . Then, 1N sodium hydroxide aqueous solution was added, the organic layer was taken, and anhydrous magnesium sulfate was added and dried. After filtration, the filtrate was concentrated under reduced pressure, and (1H-benzo [d] [1,2,3] triazo-1-yl) (3,4-dimethoxyphenyl) was recrystallized from the residue (solvent hexane-methylene chloride). ) Methanone (9 ") (19 g, 82% yield) was obtained as a white solid.
1H NMR (500 MHz, CDCl3): d 8.37 (d, J = 8.5 Hz, 1H, Ar), 8.05 (d, J = 8.5, 1H, Ar), 7.82 (s, 1H, Ar), 7.70 (t, J = 7.5 Hz, 1H, Ar), 7.55 (t, J = 7.5 Hz, 1H, Ar), 7.04 (d, J = 7.5 Hz, 1H, Ar), 4.01 (s, 3H, OCH3), 4.00 (s , 3H, OCH3); 13C NMR (125 MHz, CDCl3): d 165.5, 153.9, 148.7, 145.5, 132.5, 130.2, 127.2, 126.1, 123.3, 120.0, 114.8, 113.9, 110.2, 56.1, 56.0; MS (FAB) m / z calcd for C15H14N3O3 + (M + H) + 283, measured value 283.

実施例7:ノビレチン(1)の合成
1-(2-ヒドロキシ-3,4,5,6-テトラメトキシフェニル)エタノン(8) と (1H-ベンゾ [d][1,2,3]トリアゾ-1-イル)(3,4-ジメトキシフェニル)メタノン(9")の無水テトラヒドロフラン溶液に、アルゴン雰囲気下 -30 ℃で、1M リチウムへキサメチルジシラザンのテトラヒドロフラン溶液を加え、0 ℃に昇温し 2 時間半撹拌した。その後、飽和塩化アンモニウム水溶液を加え、ジエチルエーテルにて抽出した有機層を飽和食塩水で洗浄後、無水硫酸マグネシウムを加え乾燥した。ろ過後、ろ液を減圧濃縮し、残渣を得た。 残渣より再結晶 (溶媒ヘキサン-酢酸エチル) にてノビレチン前駆体(10) (7.8 g, 91%) を黄色固体として得た。ノビレチン前駆体 3.1 g, 7.4 mmol をメタノールに溶解させ、トリフルオロ酢酸を加えた後、50 ℃に昇温し 24 時間撹拌した。 その後減圧濃縮し、残渣を再結晶 (溶媒メタノール-ヘキサン) にてノビレチン(1) (2.9 g, 収率 98%) を淡黄色結晶として得た。
1H NMR (500 MHz, CDCl3): d 7.57 (d, J1 = 8.6 Hz, J2 = 2.1 Hz, 1H, Ar), 7.42 (d, J = 2.1, 1H, Ar), 7.00 (d, J = 8.6 Hz, 1H, Ar), 6.62 (d, 1H, CH), 4.11 (s, 3H, OCH3), 4.03 (s, 3H, OCH3), 4.00-3.95 (m, 12H, OCH3).
Example 7: Synthesis of nobiletin (1)
1- (2-hydroxy-3,4,5,6-tetramethoxyphenyl) ethanone (8) and (1H-benzo [d] [1,2,3] triazo-1-yl) (3,4-dimethoxy To an anhydrous tetrahydrofuran solution of phenyl) methanone (9 ") was added 1M lithium hexamethyldisilazane in tetrahydrofuran at -30 ° C under an argon atmosphere, and the mixture was warmed to 0 ° C and stirred for 2.5 hours. An aqueous ammonium solution was added, and the organic layer extracted with diethyl ether was washed with saturated brine, dried over anhydrous magnesium sulfate, filtered, and the filtrate was concentrated under reduced pressure to give a residue. Hexane-ethyl acetate) gave nobiletin precursor (10) (7.8 g, 91%) as a yellow solid.3.1 g, 7.4 mmol of nobiletin precursor was dissolved in methanol, and trifluoroacetic acid was added. The mixture was heated to 0 ° C. and stirred for 24 hours, and then concentrated under reduced pressure, It was obtained by nobiletin (1) (2.9 g, 98% yield) as pale yellow crystals - Recrystallization (hexane solvent methanol).
1H NMR (500 MHz, CDCl3): d 7.57 (d, J1 = 8.6 Hz, J2 = 2.1 Hz, 1H, Ar), 7.42 (d, J = 2.1, 1H, Ar), 7.00 (d, J = 8.6 Hz , 1H, Ar), 6.62 (d, 1H, CH), 4.11 (s, 3H, OCH3), 4.03 (s, 3H, OCH3), 4.00-3.95 (m, 12H, OCH3).

実施例8:ノビレチンの位置特異的標識化
ノビレチン(1) 11 mg, 27μmol の塩化メチレン溶液 1.0 mL に、0 ℃下、塩化アルミニウム 3.5 mg, 27μmol のエタンチオール 20μL溶液を加え、室温下 1 時間半撹拌した。その後、さらに 塩化アルミニウム 16 mg, 135μmol のエタンチオール 100μL 溶液を加え五時間撹拌した。TLC にて原料の消失を確認した後、反応液を0 °Cに冷却し 6N 塩酸を加え 1 時間撹拌した。次 いで、塩化メチレンにて抽出し、硫酸ナトリウムを用いて乾燥後、溶媒を留去した。残渣をシリカゲルカラムクロマトグラフィー(展開溶媒ヘキサン:酢酸エチル = 4:1 → 1:1) にて精製し、5-デメチルノビレチン(11) (9.5 mg, 収率 91%) を黄色針状結晶として得た。1H NMR (500 MHz, CDCl3): d 12..5 (s, 1H), 7.69 (d, J1 = 8.6 Hz, J2 = 2.6 Hz, 1H, Ar), 7.43 (d, J = 2.7, 1H, Ar), 7.01 (d, J = 8.6 Hz, 1H, Ar), 6.61 (s, 1H, CH), 4.12 (s, 3H, OCH3), 4.00-3.95 (m, 9H, OCH3)
次に、自動合成装置を用い、5-デメチルノビレチンを DMFに溶解させ、10% 水酸化テトラブチルアンモニウム水溶液を加えた。[11C]標識MeIを加え、封管して、1分間加熱した後冷却した。溶液の色は濃黄色から淡黄色に変化した。反応液をHPLCにて精製し、放射活性をもつ、[11C]標識ノビレチン (RT: 11 min) を得た。
Example 8: Position specific labeling of nobiletin
Nobiletin (1) 11 mg, 27 μmol of methylene chloride solution 1.0 mL was added at 0 ° C. with aluminum chloride 3.5 mg, 27 μmol of ethanethiol 20 μL solution, and stirred at room temperature for 1.5 hours. Thereafter, a solution of aluminum chloride (16 mg, 135 μmol) in ethanethiol (100 μL) was further added and stirred for 5 hours. After confirming disappearance of the raw materials by TLC, the reaction solution was cooled to 0 ° C., 6N hydrochloric acid was added, and the mixture was stirred for 1 hour. Next, the mixture was extracted with methylene chloride, dried using sodium sulfate, and the solvent was distilled off. The residue was purified by silica gel column chromatography (developing solvent hexane: ethyl acetate = 4: 1 → 1: 1), and 5-demethylnobiletin (11) (9.5 mg, yield 91%) was obtained as yellow needle-like crystals. Obtained. 1 H NMR (500 MHz, CDCl 3 ): d 12..5 (s, 1H), 7.69 (d, J 1 = 8.6 Hz, J 2 = 2.6 Hz, 1H, Ar), 7.43 (d, J = 2.7 , 1H, Ar), 7.01 (d, J = 8.6 Hz, 1H, Ar), 6.61 (s, 1H, CH), 4.12 (s, 3H, OCH 3 ), 4.00-3.95 (m, 9H, OCH 3 )
Next, using an automatic synthesizer, 5-demethylnobiletin was dissolved in DMF, and 10% tetrabutylammonium hydroxide aqueous solution was added. [11C] -labeled MeI was added, sealed, heated for 1 minute and then cooled. The color of the solution changed from dark yellow to light yellow. The reaction solution was purified by HPLC to obtain [11C] -labeled nobiletin (RT: 11 min) having radioactivity.

Claims (1)

式(I):
[式中、RはHまたはメチルである]
で表される化合物を合成する方法であって、
(a)式(II):
で表される化合物と式(III):
(式中、R ンゾトリアゾリルを表す)
で表される化合物とを反応させて、式(IV):
で表される化合物を製造し;
(b)式(IV)の化合物を環化させて、式(V):
で表される化合物を製造し;
(c)任意に、式(V)の化合物をAlCl3およびエタンチオールと反応させて、式(VI):
で表される化合物を製造する;
の各工程を含む方法。
Formula (I):
[Wherein R 1 is H or methyl]
A method for synthesizing a compound represented by:
(A) Formula (II):
And a compound represented by formula (III):
(Wherein, R represents base Nzotoriazoriru)
Is reacted with a compound represented by formula (IV):
A compound represented by:
(B) cyclizing the compound of formula (IV) to form formula (V):
A compound represented by:
(C) Optionally reacting the compound of formula (V) with AlCl 3 and ethanethiol to give formula (VI):
A compound represented by the formula:
The method including each process of these.
JP2009275181A 2009-12-03 2009-12-03 Method for producing nobiletin Active JP4559531B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2009275181A JP4559531B1 (en) 2009-12-03 2009-12-03 Method for producing nobiletin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2009275181A JP4559531B1 (en) 2009-12-03 2009-12-03 Method for producing nobiletin

Publications (2)

Publication Number Publication Date
JP4559531B1 true JP4559531B1 (en) 2010-10-06
JP2011116696A JP2011116696A (en) 2011-06-16

Family

ID=43048756

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009275181A Active JP4559531B1 (en) 2009-12-03 2009-12-03 Method for producing nobiletin

Country Status (1)

Country Link
JP (1) JP4559531B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103272032A (en) * 2013-03-29 2013-09-04 阚兆云 Natural traditional Chinese medicine composition

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3306317A1 (en) * 2016-10-04 2018-04-11 Université de Bordeaux Novel real-time multiplexed, multi-color bioluminescence resonance energy transfer assay, apparatus, and uses thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10114766A (en) * 1996-09-27 1998-05-06 Adir New flavone compound, its production and pharmaceutical composition comprising the same
JP2001514156A (en) * 1997-08-28 2001-09-11 メディケム リサーチ インコーポレイテッド Robusta flavone, intermediates, analogs and methods for their preparation
JP2003192588A (en) * 2001-12-27 2003-07-09 National Agricultural Research Organization Uv-induced prostaglandin e2 production suppressing agent
JP2009155294A (en) * 2007-12-27 2009-07-16 Yuzo Tsuchida Method for producing tricine
JP2010053067A (en) * 2008-08-28 2010-03-11 Shizuokaken Koritsu Daigaku Hojin Method of producing flavone derivative, and inhibitory agent for sialic-acid transferase

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3715779A1 (en) * 1987-05-12 1988-11-24 Kali Chemie Pharma Gmbh FLAVON-3-CARBONIC ACID COMPOUNDS AND METHOD, INTERMEDIATE PRODUCTS FOR THEIR PRODUCTION AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
CN104306367A (en) * 2004-11-08 2015-01-28 爱科来株式会社 Peroxisome proliferator-activated receptor (PPAR) activator and use thereof
WO2007083263A1 (en) * 2006-01-23 2007-07-26 Firmenich Sa Process to prepare flavones

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10114766A (en) * 1996-09-27 1998-05-06 Adir New flavone compound, its production and pharmaceutical composition comprising the same
JP2001514156A (en) * 1997-08-28 2001-09-11 メディケム リサーチ インコーポレイテッド Robusta flavone, intermediates, analogs and methods for their preparation
JP2003192588A (en) * 2001-12-27 2003-07-09 National Agricultural Research Organization Uv-induced prostaglandin e2 production suppressing agent
JP2009155294A (en) * 2007-12-27 2009-07-16 Yuzo Tsuchida Method for producing tricine
JP2010053067A (en) * 2008-08-28 2010-03-11 Shizuokaken Koritsu Daigaku Hojin Method of producing flavone derivative, and inhibitory agent for sialic-acid transferase

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103272032A (en) * 2013-03-29 2013-09-04 阚兆云 Natural traditional Chinese medicine composition

Also Published As

Publication number Publication date
JP2011116696A (en) 2011-06-16

Similar Documents

Publication Publication Date Title
US7906660B2 (en) Production of isoflavone derivatives
BRPI0719264A2 (en) NEBIVOLOL PREPARATION PROCESS
JP2012516886A (en) Clay statin manufacturing method
JP4559531B1 (en) Method for producing nobiletin
JPH03109384A (en) Production of (s)-4-hydroxymethyl-gamma-lactone
JP6230703B2 (en) Process for producing 4-benzyl-1-phenethyl-piperazine-2,6-dione, and its intermediate and process
JP6912143B2 (en) 4-Pentafluorothiophenol compounds and preparation method and preparation method of pentafluorosulfur-substituted benzopyran compound
RU2709493C1 (en) Method of producing roxadustat
CN110143927B (en) Benzimidazole chalcone derivative and preparation method and application thereof
JP3338854B2 (en) Method for producing new areno [e] indole
KR101087498B1 (en) Binaphthol aldehyde derivatives and method for preparing the same
Manchand et al. Synthesis of the leukotriene antagonist ablukast
SU751328A3 (en) Method of preparing hellebrigenine derivatives or their salts
KR101558733B1 (en) Effective synthetic method of natural product moracin N
CN110669031B (en) Total synthesis method of natural product isoperidone J
KR101122397B1 (en) An economical synthesis of ailanthoidol
CN113004245B (en) Preparation method of desloratadine
KR101558742B1 (en) New synthetic method of natural product moracin Y
JP2675569B2 (en) Method for producing 2,3-dihydrobenzofuran derivative
Padmavathi et al. Synthesis of methyl 2-methoxy-5-hydroxycinnamate, a metabolite of Murraya paniculata
JP2946423B2 (en) Process for producing aphanorphin and intermediates thereof
EP3733656A1 (en) Method for synthesis of lobaric acid and analog thereof
KR101558738B1 (en) New total synthetic method of natural product moracin S
Du et al. Asymmetric synthesis of methyl 6-deoxy-3-O-methyl-α-l-mannopyranoside from a non-carbohydrate precursor
SU726094A1 (en) 5-hydroxybenzofuran derivatives as semi-finished products for synthesis of 2-phenyl-3-acyl-4-aminomethyl-5-oxybenzofurans and their preparation method

Legal Events

Date Code Title Description
A80 Written request to apply exceptions to lack of novelty of invention

Free format text: JAPANESE INTERMEDIATE CODE: A80

Effective date: 20091218

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20100409

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20100420

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20100413

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20100420

A975 Report on accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A971005

Effective date: 20100603

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100616

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100630

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20100715

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20100722

R150 Certificate of patent or registration of utility model

Ref document number: 4559531

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130730

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250